Cargando…

Mycophenolate mofetil increases the risk of diarrhea in allogeneic hematopoietic stem cell transplantation recipients

OBJECTIVES: Mycophenolate mofetil (MMF) was reported to be a main cause of diarrhea following organ transplantation. However, research on MMF-induced diarrhea following allogeneic hematopoietic stem cell transplantation (allo-HSCT) is currently insufficient. This retrospective study examined the inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Liangmo, Hong, Mianhui, Fu, Xiangjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601400/ https://www.ncbi.nlm.nih.gov/pubmed/37879636 http://dx.doi.org/10.1177/03000605231206968

Ejemplares similares

Lower Prealbumin and Higher CRP Increase the Risk of Voriconazole Overexposure and Adverse Reactions
por: Lin, Liangmo, et al.
Publicado: (2023)

Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
por: Damlaj, Moussab, et al.
Publicado: (2017)

Effect of Mycophenolate Mofetil on Plasma Bioelements in Renal Transplant Recipients
por: Kamińska, Jolanta, et al.
Publicado: (2011)

A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis
por: Philobos, Mariana, et al.
Publicado: (2021)

Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients
por: Sunder-Plassmann, Gere, et al.
Publicado: (2012)

A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
por: Zhang, Jun, et al.
Publicado: (2018)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Serum Selenium, Iron, Zinc, and Copper Concentrations in Renal Transplant Recipients Treated with Mycophenolate Mofetil
por: Wilk, Aleksandra, et al.
Publicado: (2020)

Impact of carbapenem antibiotics on mycophenolate mofetil in hematopoietic stem cell transplant patients with interruption of the enterohepatic recycling: a retrospective study
por: Tian, Ji-Xin, et al.
Publicado: (2023)

Mycophenolate mofetil-induced oral ulcerations in solid organ transplant recipients: A report of 3 cases
por: Salik, Jonathan, et al.
Publicado: (2015)

Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients
por: Brunkhorst, Lena Caroline, et al.
Publicado: (2015)

Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients
por: Drevland, Ole Martin, et al.
Publicado: (2023)

Multivariate analysis of factors predicting surgical intervention for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
por: Yang, Wen-Bo, et al.
Publicado: (2021)

How to manage falls in hospitalized patients: A single center experience in allogeneic stem cell transplantation setting
por: Cioce, Marco, et al.
Publicado: (2022)

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
por: Kum, Elena, et al.
Publicado: (2021)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Effect of clinical condition and mycophenolate mofetil on plasma retinol, α-tocopherol and β-carotene in renal transplant recipients
por: Kamińnska, Jolanta, et al.
Publicado: (2012)

Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
por: Oh, Chang-Kwon, et al.
Publicado: (2012)

Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19: A case report
por: Chen, Dong, et al.
Publicado: (2020)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016)

Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020)

Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Correlation of abnormal histology with endoscopic findings among mycophenolate mofetil treated patients
por: Izower, Mitchell A, et al.
Publicado: (2017)

Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection
por: Dalal, Pranav, et al.
Publicado: (2009)

The Influence of Mycophenolate Mofetil and Azathioprine on the Same Cadaveric Donor Renal Transplantation
por: Joh, Jae Won, et al.
Publicado: (2005)

Acute pancreatitis induced by mycophenolate mofetil in a kidney transplant patient
por: Einollahi, Behzad, et al.
Publicado: (2015)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

A Limited Sampling Strategy for Therapeutic Drug Monitoring of Mycophenolate Mofetil for Prophylaxis of Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Transplantation
por: Gota, Vikram, et al.
Publicado: (2020)

Sirolimus and Mycophenolate Mofetil as Graft-versus-Host Disease Prophylaxis in Myeloablative, Matched Related Donor Hematopoietic Cell Transplantation
por: Johnston, L, et al.
Publicado: (2011)

Mycophenolate mofetil decreases humoral responses to three doses of SARS‐CoV‐2 vaccine in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

The Trajectory of the COVID-19 Vaccine Antibody Titers Over Time and the Association of Mycophenolate Mofetil in Solid Organ Transplant Recipients
por: Sakai, Akiyoshi, et al.
Publicado: (2022)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023)

The Burden of Gastrointestinal Complaints in Kidney Transplant Recipients Using Tacrolimus With and Without Mycophenolate Mofetil: A Randomized Controlled Study
por: Fatly, Zainab Al, et al.
Publicado: (2022)

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
por: Sheikhzadeh, Sanaz, et al.
Publicado: (2013)

Area-under-the-Curve-Based Mycophenolate Mofetil Dosage May Contribute to Decrease the Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients
por: Carlone, Giorgia, et al.
Publicado: (2021)

Toxoplasma Encephalitis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient in Korea
por: Park, Soo-Kyung, et al.
Publicado: (2012)

Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
por: Carnevale-Schianca, Fabrizio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1uv2e666o81g39nfiac0c9khjr